Wednesday, April 16, 2014

Iconic Therapeutics Finds $20M

South San Francisco-based Iconic Therapeutics announced this morning that it has raised $20M in a Series B-1 funding round. The funds came from MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic Therapeutics is developing treatments for serious eye disorders, including age-related macular degeneration (AMD). More information »